Current Clinical Trials

Studies listed below are currently open to accept new study patients. If you believe you might meet the baseline criteria, or would simply like more information, please contact us.

Condition Study Name Criteria Additonal Information
Breast Cancer Breast Cancer Screening Study
  • Are between the ages of 40-74 years old
  • Have never been diagnosed with breast cancer or DCIS
  • Have no history of mastectomy in both breasts
  • Get your mammograms in California

Introductory video: https://youtu.be/T7ws9Ewvvis

  • Participation is easy and can be done from home. There are no study visits, doctor’s appointments, or additional lab tests. You don’t need to change health care providers to be part of this study.
  • Study participation may include genetic testing, consultations with a Breast Health Specialist, and risk assessment. There will be no cost to you for these services.
  • The main study lasts for five years and involves answering a health history questionnaire and completing follow-up questionnaires every year.
  • If selected for the personalized screening group, you will be asked to provide a saliva sample, by mail, to look for genetic risk factors for breast cancer.
Cardiovascular Disease Cardiovascular Outcomes
  • Age above or equal to 18 years
  • eGFR ≥15 and < 60 mL/min/1.73 m2 (using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine equation).
  • Evidence of ASCVD by one or more of the following within the last 5 years:
    • Coronary heart disease defined as at least one of the following:
      • Documented history of MI, prior coronary revascularization procedure, or ≥50% stenosis in major epicardial coronary artery documented by cardiac catheterisation or CT coronary angiography
    • Cerebrovascular disease defined as at least one of the following:
      • Prior stroke of atherosclerotic origin, prior carotid artery revascularisation procedure, or ≥50% stenosis in carotid artery documented by X-ray angiography, MR angiography, CT angiography or Doppler ultrasound.
    • Symptomatic peripheral artery disease (PAD) defined as at least one of the following:
      • Intermittent claudication with an ankle-brachial index (ABI) ≤ 0.90 at rest, intermittent claudication with a ≥50% stenosis in peripheral artery (excluding carotid) documented by X-ray angiography, MR angiography, CT angiography or Doppler ultrasound, prior peripheral artery (excluding carotid) revascularisation procedure, or lower extremity amputation at or above ankle due to atherosclerotic disease (excluding e.g. trauma or osteomyelitis).
  • No current (or within 90 days of visit 1) chronic or intermittent haemodialysis or peritoneal dialysis.
  • No myocardial infarction, stroke, hospitalisation for unstable angina pectoris, or transient ischaemic attack within 60 days
  • No history of inflammatory bowel disease that has been clinically active during the last 12 months
  • Patients will be directed to PCP for normal care/non-study related health concerns
  • Patients will receive study medication at no cost during the course of the study
  • Patients will receive lab tests, physical exams, and study related care at no cost
  • Patients will receive reimbursement of $50 per completed office visit and $15 per completed phone visit for participating
  • The study involves about 18 office visits over approximately 4 years 
Colorectal Cancer Screening Evaluation of ctDNA LUNAR Test in an Average Patient Screening Episode
  • Patients are 55-84 years at time of consent
  • Patient is willing and able to undergo a colonoscopy.
  • Patient is considered by a physician or healthcare provider as being of ‘average risk’ for CRC
  • Patient does NOT have a known diagnosis of inflammatory bowel disease
  • Patient has NOT ever undergone a colonoscopy
  • Patient has NOT had a positive FIT/FOBT result within the previous 6 months
  • Patient does NOT have a history of colorectal cancer
  • Patients will be directed to PCP for normal care/non-study related health concerns
  • Patients may receive reimbursement for participating
  • The study consists of patients submitting stool sample through Cologuard kit and completing colonoscopy procedure
  • Time frame for participation is approximately two (2) years
Colorectal Cancer Screening Stool DNA (mt-sDNA 2.0) Test for Colorectal Cancer Screening
  • Patient is genetically male or female, 55 years of age or older.
  • Patient presents for a screening colonoscopy per standard of care.
  • Patient is willing and able to undergo a colonoscopy.
  • Patient does NOT have a diagnosis or personal history of inflammatory bowel disease (IBD)
  • Patient has NOT had a positive Cologuard, or fecal occult blood test or FIT within the previous two (2) years.
  • Patient has NOT ever undergone a colonoscopy.
  • Patient has NOT had overt rectal bleeding within the previous 30 days.
  • Patients will be directed to PCP for normal care/non-study related health concerns
  • Patients may receive reimbursement for participating
  • The study consists of patients submitting stool sample through Cologuard kit and completing colonoscopy procedure
  • Time frame for participation is approximately 60 days
Parkinson's Disease Parkinson's Disease (PD) - Online Study
  • Male or female over the age of 18
  • Diagnosis of Parkinson’s disease
  • Has Internet access to provide data online

For more information please visit:  www.foxinsight.org/clinic

  • Surveys on health-related topics to be completed every 3 months for 5 years
  • Optional, one-time surveys and sub-studies including genetic testing and counseling at no cost
  • Appointment reminders and physician reports online for patients